These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 611841

  • 1. [Use of 5,6-trans-25-OH-cholecalciferol in patients needing dialysis with florid renal osteopathy: therapeutic management and treatment results].
    Cremer W, Graben N, Merguet P.
    Verh Dtsch Ges Inn Med; ; 83():1307-10. PubMed ID: 611841
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    von Herrath D, Kraft D, Schaefer K, Krempien B.
    MMW Munch Med Wochenschr; 1974 Sep 13; 116(37):1573-8. PubMed ID: 4374654
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of 1,25-dihydroxycholecalciferol in renal osteopathy].
    Reutter FW, Sieber R, Olah AJ, Dambacher MA.
    Schweiz Med Wochenschr; 1979 Dec 08; 109(47):1880-3. PubMed ID: 531567
    [Abstract] [Full Text] [Related]

  • 4. Long-term effects of 1,25(OH)2D3 on clinical and biochemical derangements of divalent ions in dialysis patients.
    Goldstein DA, Malluche HH, Massry SG.
    Contrib Nephrol; 1980 Dec 08; 18():42-54. PubMed ID: 7353379
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Eade Y, Johnson JR, George CR, Collett P.
    Miner Electrolyte Metab; 1985 Dec 08; 11(6):358-68. PubMed ID: 3877862
    [Abstract] [Full Text] [Related]

  • 6. [Studies on intestinal 47 Calcium absorption in healthy subjects and patients with chronic renal failure as well as on the significance of vitamin D 3 or 25-hydroxycholecalciferol therapy in renal osteopathy].
    Hesch RD, Gerlach W, Henning HV, Emrich D, Scheler F, Kattermann R.
    Dtsch Med Wochenschr; 1972 Nov 10; 97(45):1735-8 passim. PubMed ID: 4343379
    [No Abstract] [Full Text] [Related]

  • 7. Hemodialysis patients with a unique mineralizing defect unresponsive to 1,25-dihydroxycholecalciferol. Dialysis osteomalacic syndrome.
    Cameron EC, Prior JC, Ballon HS.
    Contrib Nephrol; 1980 Nov 10; 18():162-71. PubMed ID: 6986229
    [Abstract] [Full Text] [Related]

  • 8. Calcium and parathyroid disorders in children. Chronic renal failure and treatment with calcitriol.
    Chan JC, DeLuca HR.
    JAMA; 1979 Mar 23; 241(12):1242-4. PubMed ID: 762789
    [Abstract] [Full Text] [Related]

  • 9. [Intestinal absorption of Ca47 in chronic renal insufficiency before and after treatment with 1,25 dihydroxycholecalciferol].
    Vattimo A.
    Minerva Med; 1979 Dec 01; 70(54):3705-7. PubMed ID: 523001
    [Abstract] [Full Text] [Related]

  • 10. Clinical effects of 1,25-dihydroxyvitamin D3 in uremic patients with overt osteodystrophy.
    Brickman AS, Coburn JW, Sherrard DJ, Wong EG, Norman AW, Singer FR.
    Contrib Nephrol; 1980 Dec 01; 18():29-41. PubMed ID: 7353378
    [No Abstract] [Full Text] [Related]

  • 11. An evaluation of 1 alpha-hydroxy-and 1,25-dihydroxyvitamin D3 in the treatment of renal bone disease.
    Kanis JA, Russell RG, Cundy T, Earnshaw M, Woods CG, Smith R, Heynen G.
    Contrib Nephrol; 1980 Dec 01; 18():12-28. PubMed ID: 7353370
    [Abstract] [Full Text] [Related]

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 13. Influence of 1,25 dihydroxycholecalciferol on sexual dysfunction and related endocrine parameters in patiens on maintenance hemodialysis.
    Blumberg A, Wildbolz A, Descoeudres C, Hennes U, Dambacher MA, Fischer JA, Weidmann P.
    Clin Nephrol; 1980 May 01; 13(5):208-14. PubMed ID: 6772366
    [Abstract] [Full Text] [Related]

  • 14. [Osteopathy and serum parathormone and 25-hydroxycholecalciferol levels in patients on long-term haemodialysis (author's transl)].
    Zazgornik J, Kokot F, Pietrek J, Schmidt P, Kopsa H.
    Wien Klin Wochenschr; 1978 Jul 14; 90(14):496-9. PubMed ID: 676306
    [Abstract] [Full Text] [Related]

  • 15. [Vitamine D3 and 25-hydroxycholecalciferol therapy in renal osteopathy: influence on serum calcium, phosphate, calcium phosphate products and on intestinal calcium absorption].
    Henning HV, Hesch RD, Hüsken WS, Quellhorst E, Scheler F.
    Verh Dtsch Ges Inn Med; 1972 Jul 14; 78():1446-8. PubMed ID: 4665578
    [No Abstract] [Full Text] [Related]

  • 16. Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trial.
    Kiilerich S, Christiansen C, Christensen MS, Naestoft J.
    Clin Nephrol; 1981 Jan 14; 15(1):23-7. PubMed ID: 7214749
    [Abstract] [Full Text] [Related]

  • 17. Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.
    Malluche HH, Goldstein DA, Massry SG.
    Contrib Nephrol; 1980 Jan 14; 18():98-104. PubMed ID: 7353383
    [No Abstract] [Full Text] [Related]

  • 18. The clinical use of synthetic 1,25-dihydroxycholecalciferol.
    Evans IM, Boulton-Jones M, Doyle FH, Joplin GF, Lockwood M, Matthews EW, MacIntyre I.
    Calcif Tissue Res; 1976 Aug 14; 21 Suppl():236-41. PubMed ID: 782663
    [No Abstract] [Full Text] [Related]

  • 19. Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.
    Henderson RG, Russell RG, Ledingham JG, Smith R, Oliver DO, Walton RJ, Small DG, Preston C, Warner GT.
    Lancet; 1974 Mar 09; 1(7854):379-84. PubMed ID: 4131033
    [No Abstract] [Full Text] [Related]

  • 20. [Calcium phosphate metabolism during therapy with 1,25-dihydroxycholecalciferol [1,25 DHCC (Ro 21/5535)] in patients with advanced kidney insufficiency].
    Schulz W, Spiegel P, Gessler U, Delling G.
    Verh Dtsch Ges Inn Med; 1978 Mar 09; (84):1297-301. PubMed ID: 741953
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.